David W. Dodington

Common problem in GI oncology – NED in Non-Neuroendocrine Carcinoma

Thor Halfdanarson, Professor of Oncology at Mayo Clinic, shared an article by David W. Dodington on X:

“Here is a common problem in GI oncology, neuroendocrine differentiation (NED) in non-neuroendocrine carcinoma.

According to many studies, outcomes are worse if NED is present (colorectum, esophagus, stomach, lung and more).

I get asked this often…”

Neuroendocrine differentiation and serotonin expression in oesophageal adenocarcinomas after neoadjuvant therapy: correlation with clinicopathological features and outcome.

Authors: David W. Dodington, et al.

Common problem in GI oncology - NED in Non-Neuroendocrine Carcinoma

cancer David W. Dodington GI oncology Mayo Clinic NED neuroendocrine differentiation Non-Neuroendocrine Carcinoma OncoDaily Oncology Serotonin Thor Halfdanarson